Westchester Capital Management, LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 48 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Westchester Capital Management, LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$5,370
+17.4%
74,9980.0%0.00%
Q2 2023$4,575
+22.0%
74,9980.0%0.00%
Q1 2023$3,750
+27.2%
74,9980.0%0.00%
Q4 2022$2,94874,9980.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,746,5860.12%
Q Global Advisors, LLC 170,785$70.01%
Atalaya Capital Management LP 225,000$9,0000.00%
MMCAP International Inc. SPC 375,000$15,0000.00%
Segantii Capital Management Ltd 5,000$53,4000.00%
DIFESA CAPITAL MANAGEMENT, LP 62,500$2,5060.00%
PERISCOPE CAPITAL INC. 957,098$38,3010.00%
Sage Rock Capital Management LP 91,999$3,6890.00%
Castle Creek Arbitrage, LLC 200,000$8,0000.00%
Context Capital Management, LLC 200,000$80.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders